Quality of Life Group
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
EORTC conducted a meta-analysis of baseline health-related quality of life (HRQOL) parameters (e.g. age, sex, distant metastases) from 30 randomized controlled trials, spanning across 11 different cancer sites. The findings suggest that HRQOL parameters and scales, when combined with socio-demographic and clinical information, provide additional prognostic information that informs treatment and can be used to help predict survival in cancer patients.